Andrew J. Einhorn - Chief Financial Officer at RVL Pharmaceuticals plc

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
RVLP
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Andrew J. Einhorn since 13 Sep 2025

Reported holdings for Andrew J. Einhorn in RVL Pharmaceuticals plc

Form 4 holding Chief Financial Officer

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
141,473
Estimated value
$4,414
Report date
24 Jan 2022
Price
$0.0312
Ownership
Direct
Form 4 holding Chief Financial Officer

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
22,852
Estimated value
$713
Report date
24 Jan 2022
Price
$0.0312
Ownership
By family limited liability company

Transaction history for Andrew J. Einhorn in RVL Pharmaceuticals plc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .